Q-Line Biotech Limited

10. Shareholding Pattern of the Company

The table below represents the shareholding pattern of our Company in accordance with Regulation 31 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as on the date of this Draft Red Herring Prospectus:

<table><thead><tr><th rowspan="2">Category</th><th rowspan="2">Category of shareholder</th><th rowspan="2">Nos. of shareholders</th><th rowspan="2">No. of fully paid up equity shares held</th><th rowspan="2">No. of partly paid-up equity shares held</th><th rowspan="2">No. of shares underlying Depository Receipts</th><th rowspan="2">Total nos. shares held</th><th rowspan="2">Shareholding as % of total no. of shares (calculated as per SCRR, 1957) As a % of (A+B+C)</th><th colspan="4">Number of Voting Rights held in each class of securities*</th><th rowspan="2">No. of Shares Underlying Outstanding convertible</th><th rowspan="2">Shareholding, as % assuming full conversion of convertible securities (as a % of diluted share capital) As a % of (A+B+C)</th><th colspan="2">Number of Locked in shares</th><th colspan="2">Number of Shares pledged or otherwise encumbered</th><th rowspan="2">Number of equity shares held in dematerialized form</th></tr><tr><th>No of Voting Rights</th><th>Class Equity Shares of Rs.10/- each</th><th>Class e.g. : y</th><th>Total</th><th>Total as a % of (A+B+C)</th><th>N o. (a)</th><th>As a % of total Shares held (b)</th><th>N o. (a)</th><th>As a % of total Shares held (b)</th></tr></thead><tbody><tr><td>I</td><td>II</td><td>III</td><td>IV</td><td>V</td><td>VI</td><td>VII = IV+V+VI</td><td>VIII</td><td>IX</td><td></td><td></td><td></td><td>X</td><td>XI=VII+X</td><td>XII</td><td>XIII</td><td>XIV</td><td></td></tr><tr><td>(A)</td><td>Promoters & Promoter Group</td><td>8</td><td>1,57,50,000</td><td>-</td><td>-</td><td>1,57,50,000</td><td>96.77</td><td>1,57,50,000</td><td>-</td><td>1,57,50,000</td><td>96.77</td><td>-</td><td>96.77</td><td>-</td><td>-</td><td>-</td><td>1,57,50,000</td></tr><tr><td>(B)</td><td>Public</td><td>16</td><td>5,24,999</td><td>-</td><td>-</td><td>5,24,999</td><td>3.23</td><td>5,24,999</td><td>-</td><td>5,24,999</td><td>3.23</td><td>-</td><td>3.23</td><td>-</td><td>-</td><td>-</td><td>0</td></tr><tr><td>(C)</td><td>Non Promoter- Non Public</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>(C1)</td><td>Shares underlying DRs</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>(C2)</td><td>Shares held by</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr></tbody></table>

76